Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Judson

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Drug and Alcohol Dependence|July 1, 1984
Naltrexone treatment of heroin addiction: one-year follow-upB A Judson, A Goldstein
Drug and Alcohol Dependence|November 1, 1979
Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilizationB A Judson, A Goldstein
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1978
Genetic control of opiate-induced locomotor activity in miceB A Judson, A Goldstein
Drug and Alcohol Dependence|October 1, 1982
Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careersB A Judson, A Goldstein
Science (New York, N.Y.)|April 16, 1971
Alcohol dependence and opiate dependence: lack of relationship in miceA Goldstein, B A Judson
Proceedings. National Conference on Methadone Treatment|January 1, 1973
Proceedings: Efficacy and side effects of three widely different methadone dosesA Goldstein, B A Judson
Drug and Alcohol Dependence|December 1, 1982
Prediction of long-term outcome for heroin addicts admitted to a methadone maintenance programB A Judson, A Goldstein
Drug and Alcohol Dependence|June 1, 1983
Episodes of heroin use during maintenance treatment with stable dosage of (-)-alpha-acetylmethadol (methadyl acetate, LAAM)B A Judson, A Goldstein
Journal of Clinical Microbiology|December 1, 1988
Improved Syva MicroTrak Chlamydia trachomatis direct test methodB A Judson, P P Lambert
British Journal of Pharmacology|January 1, 1973
Cellular and metabolic tolerance to an opioid narcotic in mouse brainA Goldstein, B A Judson, P Sheehan
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Drug and Alcohol Dependence|July 1, 1984
Naltrexone treatment of heroin addiction: one-year follow-upB A Judson, A Goldstein
Drug and Alcohol Dependence|November 1, 1979
Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilizationB A Judson, A Goldstein
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1978
Genetic control of opiate-induced locomotor activity in miceB A Judson, A Goldstein
Drug and Alcohol Dependence|October 1, 1982
Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careersB A Judson, A Goldstein
Science (New York, N.Y.)|April 16, 1971
Alcohol dependence and opiate dependence: lack of relationship in miceA Goldstein, B A Judson
Proceedings. National Conference on Methadone Treatment|January 1, 1973
Proceedings: Efficacy and side effects of three widely different methadone dosesA Goldstein, B A Judson
Drug and Alcohol Dependence|December 1, 1982
Prediction of long-term outcome for heroin addicts admitted to a methadone maintenance programB A Judson, A Goldstein
Drug and Alcohol Dependence|June 1, 1983
Episodes of heroin use during maintenance treatment with stable dosage of (-)-alpha-acetylmethadol (methadyl acetate, LAAM)B A Judson, A Goldstein
Journal of Clinical Microbiology|December 1, 1988
Improved Syva MicroTrak Chlamydia trachomatis direct test methodB A Judson, P P Lambert
British Journal of Pharmacology|January 1, 1973
Cellular and metabolic tolerance to an opioid narcotic in mouse brainA Goldstein, B A Judson, P Sheehan
Pageof 2